Clinical Evidence: What UK Patients Need to Know
Wegovy Mounjaro Clinical Trial Results: Understanding the Evidence
The weight loss results from Wegovy and Mounjaro clinical trials provide compelling evidence for both prescription treatments, though direct comparisons require careful interpretation due to different study designs and patient populations. In the landmark STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). This represented one of the most significant advances in pharmacological weight management for decades. Mounjaro's SURMOUNT-1 trial demonstrated even higher percentage weight reductions, with the highest dose showing up to 22.5% average weight loss, though these studies used different methodologies and cannot be directly compared head-to-head.
Both Wegovy and Mounjaro work by mimicking natural hormones that regulate appetite and blood sugar, but through distinct pathways that may suit different patients. Wegovy contains semaglutide, a GLP-1 receptor agonist that enhances feelings of fullness and reduces food cravings by acting on brain appetite centres. Mounjaro uses tirzepatide, which activates both GLP-1 and GIP receptors, potentially offering dual benefits for weight management and metabolic health. Your prescriber can help determine which mechanism aligns better with your individual medical profile and weight loss goals.
Wegovy Mounjaro Pricing: UK Value Comparison
EverydayMeds offers transparent pricing for both Wegovy and Mounjaro, with various bundle options to support your weight management journey without unexpected costs. Wegovy pricing starts at £79.99 for the 0.25mg starter dose after applying discount code FIRST40 for new customers, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenience for dose escalation phases, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Progress Duo (0.5mg & 1mg) for £189.99. These bundles eliminate the need for multiple orders during your initial treatment phase.
Returning customers benefit from discount code DOSE25 applied at checkout, while our 3-pen bundles offer extended supply security for patients established on maintenance doses. The Ultimate Stability Trio provides three months of 2.4mg Wegovy for £649.99, ensuring consistent treatment without supply interruptions. Mounjaro pricing follows a similar structure, with both medications requiring the same thorough clinical assessment and prescriber approval process. Payment is processed securely through our UK-registered platform, with all prices including VAT and cold-chain delivery costs.
STEP Trial Evidence for Wegovy Mounjaro Comparison
The STEP clinical trial programme established Wegovy's efficacy across diverse patient populations, with STEP 3 showing approximately clinically studied weight loss when combined with intensive behavioural therapy. STEP 5 demonstrated sustained results, with patients maintaining clinically studied weight loss at the two-year mark, addressing concerns about long-term effectiveness. Most significantly, the SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, expanding Wegovy's benefits beyond weight management alone.
These trials consistently required patients to follow a reduced-calorie diet and increased physical activity programme alongside Wegovy treatment, emphasising that medication forms part of a comprehensive lifestyle approach. The weight regain observed when treatment stopped reinforces that successful weight management requires ongoing commitment rather than short-term intervention. Both Wegovy and Mounjaro trials excluded patients with certain medical conditions, highlighting the importance of thorough clinical assessment before starting either treatment.
How Wegovy Mounjaro Mechanisms Differ for UK Patients
Understanding how Wegovy and Mounjaro work differently can help UK patients make informed treatment choices based on their individual circumstances and medical history. Wegovy's semaglutide acts specifically on GLP-1 receptors, mimicking a natural hormone released when food enters the intestine, which sends satiety signals to the brain and slows gastric emptying. This dual action reduces appetite while helping patients feel satisfied with smaller portions, making it easier to adhere to reduced-calorie eating patterns. The once-weekly injection schedule using Novo Nordisk's FlexTouch pen system provides consistent medication levels throughout the week. Clinical studies show that patients often notice appetite changes within the first few weeks of treatment, though significant weight loss typically becomes evident after several months of consistent use.
Wegovy Mounjaro Ordering Process Through EverydayMeds
Our streamlined ordering process ensures both Wegovy and Mounjaro reach UK patients safely and legally, starting with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. This assessment undergoes review by our qualified prescribers within 3 working days (or 24 hours with express service), ensuring thorough evaluation of suitability for either treatment option. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled packaging that maintains the cold chain required for injectable medications. Our GPhC-registered pharmacy (#9012878) handles all dispensing and quality control, guaranteeing authentic medication sourced directly from licensed manufacturers. Patient support continues throughout treatment, with clinical team access for questions about dose escalation, side effects, or treatment optimisation.
Storage and Practical Considerations: Wegovy Mounjaro Differences
Storage requirements represent a practical advantage for Wegovy over Mounjaro, particularly for UK patients who travel frequently or have limited refrigeration access. Wegovy pens remain stable for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit, providing greater flexibility for holidays, business travel, or emergency situations. Both medications require refrigerated storage at 2-8°C before first use and should never be frozen or exposed to direct sunlight. The FlexTouch pen system used for Wegovy allows precise dose delivery with minimal preparation, while the mandatory dose escalation schedule (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) helps minimise gastrointestinal side effects commonly experienced during treatment initiation. Proper injection technique and site rotation prevent lipodystrophy and ensure consistent medication absorption throughout your weight management programme.
UK Patient Outcomes: Real-World Wegovy Mounjaro Performance
Real-world evidence from UK patients using Wegovy through the NHS and private providers suggests that clinical trial results translate well to everyday practice when patients receive appropriate support and follow lifestyle modifications. Post-marketing surveillance indicates that patients who combine either Wegovy or Mounjaro with structured dietary counselling and regular physical activity achieve results consistent with trial data. However, individual responses vary significantly, with some patients experiencing rapid appetite suppression within weeks while others require several months to see substantial weight reduction.
The importance of realistic expectations cannot be overstated, as both medications work gradually rather than providing immediate dramatic changes. UK prescribing guidelines emphasise that weight loss medications should be discontinued if patients fail to lose at least 5% of initial body weight after 3-6 months of treatment at therapeutic doses. This approach ensures that patients derive meaningful benefit while avoiding unnecessary expense or side effects from ineffective treatment continuation.
Making Your Wegovy Mounjaro Decision with EverydayMeds
Choosing between Wegovy and Mounjaro requires careful consideration of your medical history, lifestyle factors, storage needs, and cost considerations, with both prescription-only medicines available through our comprehensive UK service. Our clinical team can provide detailed guidance on which treatment aligns better with your specific circumstances, considering factors such as previous weight loss attempts, current medications, and any underlying health conditions that might influence treatment selection. The 3-minute assessment process captures this essential information, enabling our prescribers to make evidence-based recommendations tailored to your individual profile. Both treatments require the same commitment to dietary changes and increased physical activity, making your dedication to lifestyle modifications more important than the specific medication chosen. Start your assessment today using discount code FIRST40 for new customers or DOSE25 for returning patients, and take the first step towards clinically-proven weight management with expert UK medical oversight.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
